HHealth care Read More UnitedHealth’s massive growth just got harder to trackMarch 9, 2026 Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
BBusiness Read More FDA, urged to avoid controversy, creates new headache with attack on UniQureMarch 6, 2026 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…
HHealth care Read More Health data as a public utility: A former ARPA-H data chief explainsMarch 6, 2026 Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
HHealth care Read More Science Corp. raises $230 million as it awaits FDA decisionMarch 6, 2026 O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming…
HHealth care Read More FDA offers clues to AI regulation with RecovryAI designationMarch 3, 2026 Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
HHealth care Read More Cigna acquires CarepathRx, a major pharmacy used by hospitalsMarch 1, 2026 Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
SSports Read More Gamecocks Down No. 11 Clemson 7-0 – Clemson Tigers Official Athletics SiteFebruary 28, 2026 Box Score (HTML) | Box Score (PDF) COLUMBIA, S.C. – Junior righthander Josh Gunther pitched 7.0 strong innings…
NNutrition Read More Why clinical trials on nutritional supplements are hard to designFebruary 27, 2026 Walk into any drugstore, natural market, or Costco and you’ll find a dazzling array of supplements promising everything…
HHealth care Read More Digital twins in health care: Promising technology still years awayFebruary 24, 2026 Two decades ago, futurist Ray Kurzweil laid out a bold vision for next-generation medicine in his book “The…
BBusiness Read More Gilead to buy Arcellx in nearly $8B dealFebruary 24, 2026 Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…